Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE4157.3064.15 (+1.57 %)
PREV CLOSE () 4093.15
OPEN PRICE () 4148.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4615
TODAY'S LOW / HIGH ()4082.40 4165.80
52 WK LOW / HIGH ()3101 4479.7
NSE4155.2060.7 (+1.48 %)
PREV CLOSE() 4094.50
OPEN PRICE () 4116.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 4155.20 (101)
VOLUME 354702
TODAY'S LOW / HIGH() 4074.60 4160.00
52 WK LOW / HIGH ()3101.6 4482.9
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1972

Management Info :

Samir Mehta - Chairman Aman Mehta - Managing Director

Registered Office :

Address : Avirat,Thaltej Shilaj Road, ,
Ahmedabad,
Gujarat-380059

Phone : 079-26599000

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
21Mar Torrent Pharmaceuticals launches Semag
Torrent Pharmaceuticals has launched its Semaglutide brands - Sembolic a..
13Feb Torrent Pharmaceuticals reports 26% ri
Torrent Pharmaceuticals has reported results for third quarter ended Dec..
02Feb Torrent Pharmaceuticals informs about
Torrent Pharmaceuticals has informed that a meeting of the Board of Dire..
27Jan Torrent Pharmaceuticals rises on acqui
Torrent Pharmaceuticals is currently trading at Rs. 3967.70, up by 40.75..
24Jan Torrent Pharmaceuticals acquires stake
Torrent Pharmaceuticals has acquired 37,82,566 equity shares of J.B. Che..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit577018880
Gross Profit 7570 26100
Operating Profit 992036070
Net Sales 2599096820
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 8291.50 (2.93%)
M.Cap ( in Cr)
20728.75
Neuland Laboratories (BSE)
 14948.95 (1.46%)
M.Cap ( in Cr)
19179.34
Divi's Lab (BSE)
 6119.50 (2.72%)
M.Cap ( in Cr)
162453.50
Procter&Gamble Healt (BSE)
 4943.65 (2.88%)
M.Cap ( in Cr)
8206.15
Pfizer (BSE)
 4865.30 (2.46%)
M.Cap ( in Cr)
22257.64
Shareholding Pattern
PROMOTERS 68.31%
NON-INSTITUTION 6.42%
MUTUAL FUNDS/UTI 4.83%
FI/BANKS/INSURANCE 1.72%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77550.25918.60 (1.20%)
NIFTY24050.60275.50 (1.16%)
Dow Jones 47916.57-269.23 (-0.56%)
Nasdaq 22902.8980.47 (0.35%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI